Related references
Note: Only part of the references are listed.Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
Michelle Rosenzwajg et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis
Charlotte Klasen et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis
Dao Xuan Nguyen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis
Adam P. Cribbs et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Interleukin-6 Receptor Blockade Enhances CD39+Regulatory T Cell Development in Rheumatoid Arthritis and in Experimental Arthritis
A. Thiolat et al.
ARTHRITIS & RHEUMATOLOGY (2014)
CD28 Costimulation Impairs the Efficacy of a Redirected T-cell Antitumor Attack in the Presence of Regulatory T cells Which Can Be Overcome by Preventing Lck Activation
David M. Kofler et al.
MOLECULAR THERAPY (2011)
Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma
C Karagiannidis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Share Paper
